Becker's Healthcare September 13, 2022
On average, safety net hospitals raised prices of oncology drugs 4.9 times their 340B purchased costs — and one breast cancer drug was hiked 11.3 percent — according to a September 2022 report from the Community Oncology Alliance.
The COA evaluated 49 top acute care hospitals with a disproportionately large number of uninsured and under-insured patients. Based on the assumption that these hospitals gained a 34.7 percent discount on the drugs, markups ranged from 3.2 percent to 11.3 percent, according to the report.
Cost variation happened within each hospital, too, depending on each patient’s...
Today's Sponsors
Today's Sponsor